A previous study has demonstrated that NSA2 is activated after permanent middle cerebral occlusion in an Alzheimer’s disease mouse model (Tseveleki et al., 2010); NSA2 was predicted to be related to brain defense and tissue repair in the pathological process of Alzheimer’s disease. This evidence concerns the gene NSA2 and early-onset autosomal dominant Alzheimer disease.